UncategorizedProton Intelligence lands funding to advance continuous potassium monitoring technology Empower Meds / November 25, 2025
Uncategorized‘The next frontier of longevity – human healthspan resilience’ Empower Meds / November 25, 2025
UncategorizedNew deal to develop therapy targeting deadly heart risk Empower Meds / November 25, 2025
UncategorizedAmylyx puts ‘long-acting’ GLP-1 development front and center in new collab Empower Meds / November 25, 2025
